Sign In
The CEO Views Small logos
  • Home
  • Technology
    Artificial Intelligence
    Big Data
    Block Chain
    BYOD
    Cloud
    Cyber Security
    Data Center
    Digital Transformation
    Enterprise Mobility
    Enterprise Software
    IOT
    IT Services
    Innovation
  • Platforms
    How IBM Maximo Is Revolutionizing Asset Management
    How IBM Maximo Is Revolutionizing Asset Management
    IBM
    7 Min Read
    Optimizing Resources: Oracle DBA Support Services for Efficient Database Management
    Oracle
    Oracle
    9 Min Read
    The New Google Algorithm Update for 2021
    google algorithm update 2021
    Google
    5 Min Read
    Oracle Cloud Platform Now Validated for India Stack
    Service Partner Horizontal
    Oracle
    3 Min Read
    Oracle and AT&T Enter into Strategic Agreement
    oracle
    Oracle
    3 Min Read
    Check out more:
    • Google
    • HP
    • IBM
    • Oracle
  • Industry
    Banking & Insurance
    Biotech
    Construction
    Education
    Financial Services
    Healthcare
    Manufacturing
    Mining
    Public Sector
    Retail
    Telecom
    Utilities
    Gaming
    Legal
  • Functions
    RISMA Systems: A Comprehensive Approach to Governance, Risk and Compliance
    Risma Systems
    ENTREPRENEUR VIEWSGDPR
    9 Min Read
    Happiest Minds: A “Privacy by Design” approach is key to creating GDPR compliant businesses
    Happiest Minds 1
    GDPR
    8 Min Read
    Gemserv: GDPR 2020 and Beyond
    Gemserv 1
    GDPR
    9 Min Read
    ECCENCA:GDPR IS STILL AN UNTAMED ANIMAL
    eccenca 1
    GDPR
    6 Min Read
    Boldon James: HOW ENTERPRISES CAN MITIGATE THE GROWING THREATS OF DATA
    Boldon James 1
    GDPR
    8 Min Read
    Check out more:
    • GDPR
  • Magazines
  • Entrepreneurs Views
  • Editor’s Bucket
  • Press Release
  • Micro Blog
  • Events
Reading: End-to-end healthcare technology solution provider to humanize the existing clinical conditions
Share
The CEO Views
Aa
  • Home
  • Magazines
  • Enterpreneurs Views
  • Editor’s Bucket
  • Press Release
  • Micro Blog
Search
  • World’s Best Magazines
  • Technology
    • Artificial Intelligence
    • Big Data
    • Block Chain
    • BYOD
    • Cloud
    • Cyber Security
    • Data Center
    • Digital Transformation
    • Enterprise Mobility
    • Enterprise Software
    • IOT
    • IT Services
  • Platforms
    • Google
    • HP
    • IBM
    • Oracle
  • Industry
    • Banking & Insurance
    • Biotech
    • Construction
    • Education
    • Financial Services
    • Healthcare
    • Manufacturing
    • Mining
    • Public Sector
    • Retail
    • Telecom
    • Utilities
  • Functions
    • GDPR
  • Magazines
  • Editor’s Bucket
  • Press Release
  • Micro Blog
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
The CEO Views > Blog > Industry > Healthcare > End-to-end healthcare technology solution provider to humanize the existing clinical conditions
HealthcareMagazine

End-to-end healthcare technology solution provider to humanize the existing clinical conditions

The CEO Views
Last updated: 2024/03/06 at 7:06 AM
The CEO Views
Share
Emily Reichart Head of Market Development 1
Emily Reichart Head of Market Development 1

By: Nish Chasmawala, CEO, Consure Medical, Inc.

Innovation and scientific breakthroughs are transforming the healthcare world. Despite the skepticism that is prevalent today, we will make more progress in improving care in the next twenty years than the last ten decades combined.

Background:

Consure Medical was founded to address the latent clinical need of fecal incontinence (FI) in non-ambulatory patients. FI is a clinical condition where the neuro-muscular apparatus of the anorectal anatomy is compromised, leading to the unwanted and untimely passage of bodily excretions. FI impacts more than 100 million patients each year and has an associated cost of care of over $20 Billion. Furthermore, there is a significant stigma associated with this condition that has a profound impact on the psyche of patients.

The goal of Consure Medical is to humanize this clinical condition and take a very patient-centric approach to develop novel management, diagnostic and therapeutic solutions. The company’s first product, Qora Stool Management Kits (SMK), is novel and has received accolades from patients, family members, and care providers, alike. The inherent technology of Qora not only alleviates the clinical complications in the form of dermatitis, maceration, and injury to anatomy, but its simplicity of design has expanded the coverage of use from ICUs and trauma facilities, to nursing homes, hospice care, and in select markets, even for patients that are at home.

Innovating with and for the Nurses:

The recognition of a vital problem and collaboration of care providers are the secret ingredients for innovation to take root and prosper. Prior to founding Consure Medical, the founders and inventors spent thousands of hours in hospitals following nurses to understand the larger treatment landscape in addition to their thought processes in triaging and prioritizing a myriad of care protocols available to them. The nurses worked closely with the technical team in designing product features, kit configuration, clinical programs, subsequent marketing claims, and peer reviewed publications. Since the launch of Qora SMK across care facilities in the USA, UK, India, and Israel, the team has incorporated additional nurses into the team. Consure Medical is preparing to launch its fourth generation (Gen IV) of product later this year.

Nurses are deeply appreciative of the high-quality product designed by the development team at Consure Medical. The product prevents nurses from carrying clostridium-difficile pathogens into their homes and to their families.

Our unique and mutually beneficial collaboration with nurses is helping them prevent the spread of nosocomial infections related to blood stream, surgical site, urine and clostridium difficile, saving the hospitals over $30,000 per infected patient. The advent of the Affordable Care Act (ACA), linking hospital acquired complications and infections to the overall reimbursement, has created a tremendous pull for the novel product. Independent studies conducted by nurses show a far greater improvement in quality metrics than those predicted and claimed by Consure Medical.

Managing Condition to Disease Management:

Consure Medical is now collaborating with thought leaders at key hospitals to deliver on its vision of becoming a leading lower GI disorder management and treatment company. The company has developed a technology platform that enables the nurses to not only manage the incontinence episodes, but also provides them with additional tools for definitive therapy selection and deployment. This technology is data driven, relies on proven pharmacological principles, interfaces well in the current care regime, and has integrated optimization modules.

The technology has the potential to improve diagnosis and treatment for patients suffering from profuse incontinent episodes, and reduce the overall length of stay in acute care settings by over 25%. Furthermore, the technology can reduce mortality by over 15% and significantly avoid comorbidities with longer hospital stays.

Another area where Consure Medical is contributing immensely in healthcare is towards a better understanding of the gut microbiome. Often times, patients preemptively make certain diet modifications that may either not be helpful in recovery, or even worse, may be harmful in the long run. While there are benefits related to a short-term cleanse of the GI tract, its long-term impact has not been well documented. While clinical conditions like sepsis or major infectious bouts offset the microbes in the GI tract, a reverse fluctuation may be equally harmful.

As Consure Medical continues to scale Qora SMK, the company will soon become the largest repository of gut microbial samples and perhaps even data. The goal of the company is to build on its collaboration with care providers and develop novel data driven therapies for the diagnosis and treatment of Irritable Bowel Disease, Celiac Disease, Crohn’s disease, etc.

Future of GI Diseases:

Evidence based medicine has long been the mantra for nurses and care providers. With the advent of powerful analytical tools, the patient’s baseline data now can be analyzed against a larger dataset of evidence before making comprehensive clinical decisions. We envision that such an approach will help nurses refine their care protocols and will further help them to make faster and more accurate clinical decisions on complex patients with multiple comorbidities. The microbiome is more complex than genetic cells – some even refer to it as a new organ. We have not even scraped the tip of iceberg when it comes to GI disorders and the linkages with neuro (gut-brain research is witnessing an unprecedented investment), and the impact on other inflammatory diseases. All of us at Consure Medical are excited to be part of this ecosystem and positively impact healthcare in our own way.

The CEO Views July 24, 2019
Share this Article
Facebook Twitter LinkedIn Email Copy Link
Previous Article Mark Crockett CEO 1 Why struggling hospitals can no longer view zero-harm as “UNACHIEVABLE”
Next Article Mark Griffin President Blue Eagle: For Customized IT Service Management
How Startups Can Overcome Tech Challenges

How Startups Can Overcome Tech Challenges

February 21, 2025
Data Integration
Micro Blog

Data Integration 101: Essential Concepts for Every Business

The CEO Views By The CEO Views October 24, 2024
pexels thisisengineering 3861957 scaled 1
Editor's Bucket

The Top 10 Approaches for Effective Analytics Outcomes

The CEO Views By The CEO Views February 16, 2024
CEO Stories From Online Gambling
Micro Blog

CEO Stories From Online Gambling: How To Build A Casino Empire

The CEO Views By The CEO Views April 29, 2025
vr 1911451 640
Digital Transformation

The Ultimate Business Guide to AR and VR: Everything You Need to Know

The CEO Views By The CEO Views March 11, 2024

How to Do Online Casino Marketing

May 30, 2025

From Boardroom to Marketplace: How CEOs Are Driving Amazon Success

May 30, 2025

A Look at South Florida’s Top Personal Injury Law Firm, Hollander Law Firm Accident Injury Lawyers

May 30, 2025

The Digital Revolution Is Here – And Legacy Payment Systems Are Struggling To Keep Up

May 29, 2025

You Might Also Like

6 Emerging Healthcare Technologies Transforming Patient Recovery
Healthcare

6 Emerging Healthcare Technologies Transforming Patient Recovery

7 Min Read
Mike Akard
ENTREPRENEUR VIEWS

A Legacy of Innovation and Excellence

14 Min Read
Nathan Udy, President & CEO
ENTREPRENEUR VIEWS

Nathan Udy: A Visionary Leader Rebuilding the Benefits System

8 Min Read
Jason Lau, CEO
ENTREPRENEUR VIEWS

Jason Lau: Leading with Problem-solving, Adaptability, and Commitment to Long-term Success

8 Min Read
Small logos Small logos

© 2025 All rights reserved. The CEO Views

  • About Us
  • Privacy Policy
  • Advertise with us
  • Reprints and Permissions
  • Business Magazines
  • Contact
Reading: End-to-end healthcare technology solution provider to humanize the existing clinical conditions
Share

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?